VEGFA and endometriosis: It has been reported that the administration of bevacizumab, a VEGF-A antibody, resulted in reduced lesion formation in mouse endometriosis model studies41, suggesting neovascularization of ectopic endometrial tissue is crucial in the development of the endometriotic-like lesion.